"Is it time for some cell therapy M&A?
Investors of Iovance Biotherapeutics certainly thought so, sending its stock $IOVA up as much as 40% after Bloomberg reported that the cancer-focused biotech is talking to potential buyers."
Its stock movements like this that prove that if you are for sale, then you "deserve" a lot higher stock price.
They are the exact same company as the day before.
I think if SGMO announced they not against considering a sale, they would go up 100%+ in a short period of time.